CST3 and chronic kidney disease: The strengths of this study, in addition to the prospective design and large sample size, are the use of cystatin C (muscle mass and function independent) for identifying CKD, the detailed assessment of muscle composition (muscle volume and MFI) with MRI, and the use of quantitative muscle biomarkers.